Evidence map›Paper›PMID 40419763›Full record

ArticleNature cancer2025

Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions.

Alexander Beck, Lisa Gabler-Pamer, Gustavo Alencastro Veiga Cruzeiro, Sander Lambo, Bernhard Englinger, McKenzie L Shaw, Olivia A Hack, Ilon Liu, Rebecca D Haase, Carlos A O de Biagi and 31 more

Abstract readCase Reports
In one paragraph

Article in Nature cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. "Updates on diagnostic and prognostic molecular biomarkers of CNS tumors".Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  2. Review
  3. Review
  4. MUW researcher of the month: Dr.in Lisa Gabler-Pamer.Wiener klinische Wochenschrift · 2026
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Alexander Beck *Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8641-7832
Lisa Gabler-Pamer *Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Gustavo Alencastro Veiga CruzeiroDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Sander LamboDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Bernhard EnglingerDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
McKenzie L ShawDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Olivia A HackDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Ilon LiuDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6186-3630
Rebecca D HaaseDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Carlos A O de BiagiDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0700-3135
Alicia BaumgartnerDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Andrezza Do Nascimento SilvaDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Marbod KlennerCenter for Neuropathology, Ludwig-Maximilians-University Munich, Munich, Germany.
Pia S FreidelCenter for Neuropathology, Ludwig-Maximilians-University Munich, Munich, Germany.
Jochen HermsCenter for Neuropathology, Ludwig-Maximilians-University Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-6201-1042
Louisa von BaumgartenDepartment of Neurosurgery, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-6634-0927
Joerg C TonnDepartment of Neurosurgery, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany.ORCID http://orcid.org/0009-0004-1756-423X
Niklas ThonDepartment of Neurosurgery, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany.
Katharina BrucknerDepartment of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-6633-4009
Sibylle MadlenerDepartment of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-7099-9997
Lisa MayrDepartment of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-6841-0749
Daniel SenfterDepartment of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Andreas PeyrlDepartment of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-5736-8231
Irene SlavcDepartment of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-9419-6790
Daniela LötschDepartment of Neurosurgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Christian DorferDepartment of Neurosurgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-1843-7732
Rene GeyreggerClinical Cell Biology and FACS Core Unit, St. Anna Children's Cancer Research Institute, Vienna, Austria.
Nicole AmbergDepartment of Neurology, Division of Neuropathology and Neurochemistry and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-3183-8207
Christine HaberlerDepartment of Neurology, Division of Neuropathology and Neurochemistry and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Norman MackDivision of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Benjamin SchwalmDivision of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Stefan M PfisterDivision of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-5447-5322
Andrey KorshunovHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Lissa C BairdDepartment of Neurosurgery, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7996-1020
Edward YangDepartment of Radiology, Boston Children's Hospital, Boston, MA, USA.
Susan N ChiDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7753-878X
Sanda AlexandrescuDepartment of Pathology, Boston Children's Hospital, Boston, MA, USA.
Johannes GojoDepartment of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Marcel KoolDivision of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-6557-5468
Volker HovestadtDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. volker_hovestadt@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-3480-6649
Mariella G FilbinDepartment of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. mariella.filbin@childrens.harvard.edu.ORCID http://orcid.org/0000-0002-2613-8126

Funding

How the 3D Architecture of the Brain Shapes Cancer Cell Fate DecisionsDP2NS127705 · NINDS · DANA-FARBER CANCER INST · PI FILBIN, MARIELLA GRUBER · 2021 to 2024
$2.7M
NINDS NIH HHS DP2 NS127705
6 · The paper itself

Abstract

Embryonal tumor with multilayered rosettes (ETMR) is a pediatric brain tumor with dismal prognosis. Characteristic alterations of the chromosome 19 microRNA cluster (C19MC) are observed in most ETMR; however, the ramifications of C19MC activation and the complex cellular architecture of ETMR remain understudied. Here we analyze 11 ETMR samples from patients using single-cell transcriptomics and multiplexed spatial imaging. We reveal a spatially distinct cellular hierarchy that spans highly proliferative neural stem-like cells and more differentiated neuron-like cells. C19MC is predominantly expressed in stem-like cells and controls a transcriptional network governing stemness and lineage commitment, as resolved by genome-wide analysis of microRNA-mRNA binding. Systematic analysis of receptor-ligand interactions between malignant cell types reveals fibroblast growth factor receptor and Notch signaling as oncogenic pathways that can be successfully targeted in preclinical models and in one patient with ETMR. Our study provides fundamental insights into ETMR pathobiology and a powerful rationale for more effective targeted therapies.

Indexed as

BrainMicroRNAsNeoplasms, Germ Cell and EmbryonalAntineoplastic AgentsBrain NeoplasmsCarcinogenesisChild, PreschoolChromosomes, Human, Pair 19HEK293 CellsHumansMaleNeurogenesisPyrazolesQuinoxalinesSignal TransductionSingle-Cell Gene Expression AnalysisAntineoplastic AgentserdafitinibMicroRNAsPyrazolesQuinoxalines

Identifiers

PMID40419763
PMCPMC12202505

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.